Featured Articles

bacteria

Is The Cidara Therapeutics Inc (NASDAQ:CDTX) Crash An Opportunity?

Cidara Therapeutics Inc (NASDAQ:CDTX) just announced data from a phase 2 study of one of its lead indications, and the outcome was unfavorable. On...

Latest News

Market Exclusive Biotech News & Analysis

pfizer-inc

Manufacturing Delay Of Generic Drug From Pfizer Inc. (NYSE:PFE) A Relief...

Pfizer Inc. (NYSE:PFE) has been slapped with a warning letter by the Food and Drug Administration in regards to one of its fill/finish factories....
Boston Scientific Corporation

Boston Scientific Corporation (NYSE:BSX) Loses On A $309M Appeal At US...

An appeal by Boston Scientific Corporation (NYSE:BSX) has been declined by the U.S. Supreme Court. The appeal was seeking a recovery of a $309...

Popular Posts

Market News